To cultivate HCECs, corneal limbal tissue was placed in a Petri dish containing Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen Corp., Carlsbad, CA), 50 U/mL penicillin, and 50 μg/mL streptomycin. Under a dissecting microscope, Descemet’s membrane with its attached corneal endothelium 1 mm apart from trabecular meshwork was stripped from the stroma and placed in a 35-mm dish containing 1.2 U/mL dispase in phosphate-buffered saline (PBS). The tissue was incubated for 1 hour at 37°C, and the cells were rinsed gently with a sterile pipette. The dispase was then inactivated by suspending the cells in a medium containing DMEM, 50 U/mL penicillin, and 50 μg/mL streptomycin. After gentle centrifugation (3 minutes at 180g), the cells were resuspended in culture medium containing DMEM, 50 U/mL penicillin, 50 μg/mL streptomycin, 10% fetal bovine serum (ICN Biomedicals, Inc., Aurora, OH), and 2 ng/mL basic fibroblast growth factor (Invitrogen Corp.).
The cells were incubated in wells of a collagen IV–coated 24-well plate at 37°C in 5% carbon dioxide-95% humidified air. The medium was changed every other day. Cells reached confluence in 10 to 20 days and were then subcultured by treatment with trypsin-EDTA (Invitrogen Corp.) and seeded at a ratio of 1:2 to 1:8.